Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01876251
Title A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | ESP | BEL

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35233 United States Details
University of Alabama at Birmingham, IDS Pharmacy Birmingham Alabama 35249 United States Details
University of Alabama at Birmingham Birmingham Alabama 35249 United States Details
Stanford Cancer Institute Stanford California 94305 United States Details
Stanford Hospital & Clinics-DRUG SHIPMENT ADDRESS only Stanford California 94305 United States Details
Stanford Hospital & Clinics Stanford California 94305 United States Details
Stanford Women's Cancer Center Stanford California 94305 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Karmanos Cancer Institute (KCI) Detroit Michigan 48201 United States Details
UNC Cancer Hospital Infusion Pharmacy Chapel Hill North Carolina 27514 United States Details
UNC Hospitals, The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599-7600 United States Details
Jules Bordet Institut Bruxelles 1000 Belgium Details
Grand Hopital de Charleroi Charleroi 6000 Belgium Details
Instituto Europeo di Oncologia Milano 20141 Italy Details
Instituto Catalan de Oncologia de L'Hospitalet de Llobregat(ICO) Barcelona 08908 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field